Breast Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who are 18 years of age or older at the time of signing up, both male and female.
- People who can understand written and/or spoken English.
- People who are able to give informed consent to participate.
- People who have been diagnosed with cancer of any type.
- People who have either been recently diagnosed with cancer and not yet received treatment, or who have an existing cancer diagnosis but have not had any active cancer treatment for more than one month (for reasons such as the cancer returning, the cancer getting worse, the cancer not responding to treatment, or not being able to tolerate treatment).
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who are under 18 years of age.
- People who are not expected to be able to complete the breath sample collection process.
- People who are unable to give informed consent.
- People who are pregnant.
- People who currently have symptoms of an active respiratory infection (such as a chest or breathing infection).
- People who have recently used antibiotics (confirm with trial site for timeframe).
- People who have difficulty breathing out in a controlled way when guided to do so.
- People who are unable to follow instructions.
- Cancer patients who are currently receiving cancer treatment or who have received cancer treatment within the past month.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Nirmal Choradia, MD, University of Oklahoma - Stephenson Cancer Center
Phone: 405-271-8777
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
VOC Signature Collection.; Assess the sensitivity of Machine Learning (ML) Algorithm In The Test Dataset.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 18 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.